Who We Are
Auxergen applies novel biocontrol solutions to human, agricultural and environmental disease, to reduce the chemical loading of our soils and waterways.
For plant health, we are developing phage-based cures for Xylella Fastidiosa disease in olive, grapes, oleander, etc., and Xanthamonas disease of citrus, rice, bananas, and cruciferous vegetables.
In human health, we are proud to introduce, under the brand VIE+, an irritation-free, botanical skin cream which lifts, tightens, lightens and removes spots, evens tone, improves microcirculation, and radiance. Look for Jeunase(TM) Rejuvenating Cream in September 2022, available at vieplus.com.
Auxergen is a Maryland "Qualified Maryland Biotechnology Company," so designated by the Maryland Department of Commerce, enabling tax credits to Auxergen investors to promote biotech R&D in Maryland.
For plant health, we are developing phage-based cures for Xylella Fastidiosa disease in olive, grapes, oleander, etc., and Xanthamonas disease of citrus, rice, bananas, and cruciferous vegetables.
In human health, we are proud to introduce, under the brand VIE+, an irritation-free, botanical skin cream which lifts, tightens, lightens and removes spots, evens tone, improves microcirculation, and radiance. Look for Jeunase(TM) Rejuvenating Cream in September 2022, available at vieplus.com.
Auxergen is a Maryland "Qualified Maryland Biotechnology Company," so designated by the Maryland Department of Commerce, enabling tax credits to Auxergen investors to promote biotech R&D in Maryland.
Auxergen is located at Columbus Center, 701 East Pratt Street, Lab 4011, Baltimore, MD 21202, part of the University of Maryland's Harbor Launch Incubator Program at the Institute for Marine and Environmental Technology.
